Polymorphisms of the DNMT3B gene and risk of squamous cell carcinoma of the head and neck: A case-control study

Cancer Letters

Volumn 268, Issue 1, 2008, Pages 158-165

  Liu, Zhensheng ^a   Wang, Luo ^a   Wang, Li E ^a   Sturgis, Erich M ^a   Wei, Qingyi ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

Cancer risk; DNMT3B; Methylation; Molecular epidemiology; Polymorphism

Indexed keywords

DNA METHYLTRANSFERASE 3B;

ADULT; ALCOHOL CONSUMPTION; ARTICLE; CANCER RISK; CASE CONTROL STUDY; CAUCASIAN; CONTROLLED STUDY; FEMALE; GENETIC POLYMORPHISM; GENOTYPE; HEAD AND NECK CARCINOMA; HUMAN; LARYNX CANCER; MAJOR CLINICAL STUDY; MALE; MOLECULAR EPIDEMIOLOGY; PHARYNX CANCER; PRIORITY JOURNAL; PROMOTER REGION; SINGLE NUCLEOTIDE POLYMORPHISM; SMOKING; SQUAMOUS CELL CARCINOMA; STATISTICAL ANALYSIS;

CARCINOMA, SQUAMOUS CELL; CASE-CONTROL STUDIES; DNA (CYTOSINE-5-)-METHYLTRANSFERASE; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HEAD AND NECK NEOPLASMS; HUMANS; MALE; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; PROMOTER REGIONS (GENETICS); RISK;

EID: 48149099598     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.canlet.2008.03.034     Document Type: Article

References (30)

1. Forastiere A., Koch W., Trotti A., and Sidransky D. Head and neck cancer. N. Engl. J. Med. 345 (2001) 1890-1900
2. Neumann A.S., Sturgis E.M., and Wei Q. Nucleotide excision repair as a marker for susceptibility to tobacco-related cancers: a review of molecular epidemiological studies. Mol. Carcinog. 42 (2005) 65-92
3. Perez-Ordonez B., Beauchemin M., and Jordan R.C. Molecular biology of squamous cell carcinoma of the head and neck. J. Clin. Pathol. 59 (2006) 445-453
4. Hogg R.P., Honorio S., Martinez A., Agathanggelou A., Dallol A., Fullwood P., Weichselbaum R., Kuo M.J., Maher E.R., and Latif F. Frequent 3p allele loss and epigenetic inactivation of the RASSF1A tumour suppressor gene from region 3p21.3 in head and neck squamous cell carcinoma. Eur. J. Cancer 38 (2002) 1585-1592
5. Reed A.L., Califano J., Cairns P., Westra W.H., Jones R.M., Koch W., Ahrendt S., Eby Y., Sewell D., Nawroz H., Bartek J., and Sidransky D. High frequency of p16 (CDKN2/MTS-1/INK4A) inactivation in head and neck squamous cell carcinoma. Cancer Res. 56 (1996) 3630-3633
6. Wang J., Walsh G., Liu D.D., Lee J.J., and Mao L. Expression of {Delta}DNMT3B variants and its association with promoter methylation of p16 and RASSF1A in primary non-small cell lung cancer. Cancer Res. 66 (2006) 8361-8366
7. Hermann A., Gowher H., and Jeltsch A. Biochemistry and biology of mammalian DNA methyltransferases. Cell. Mol. Life Sci. 61 (2004) 2571-2587
8. Luczak M.W., and Jagodzinski P.P. The role of DNA methylation in cancer development. Folia Histochem. Cytobiol. 44 (2006) 143-154
9. Turek-Plewa J., and Jagodzinski P.P. The role of mammalian DNA methyltransferases in the regulation of gene expression. Cell. Mol. Biol. Lett. 10 (2005) 631-647
10. Jeltsch A. Molecular enzymology of mammalian DNA methyltransferases. Curr. Top. Microbiol. Immunol. 301 (2006) 203-225
11. Jones J.S., Amos C.I., Pande M., Gu X., Chen J., Campos I.M., Wei Q., Rodriguez-Bigas M., Lynch P.M., and Frazier M.L. DNMT3B polymorphism and hereditary nonpolyposis colorectal cancer age of onset. Cancer Epidemiol. Biomarkers Prev. 15 (2006) 886-891
12. Montgomery K.G., Liu M.C., Eccles D.M., and Campbell I.G. The DNMT3B C → T promoter polymorphism and risk of breast cancer in a British population: a case-control study. Breast Cancer Res. 6 (2004) R390-R394
13. Shen H., Wang L., Spitz M.R., Hong W.K., Mao L., and Wei Q. A novel polymorphism in human cytosine DNA-methyltransferase-3B promoter is associated with an increased risk of lung cancer. Cancer Res. 62 (2002) 4992-4995
14. Singal R., Das P.M., Manoharan M., Reis I.M., and Schlesselman J.J. Polymorphisms in the DNA methyltransferase 3B gene and prostate cancer risk. Oncol. Rep. 14 (2005) 569-573
15. Lee S.J., Jeon H.S., Jang J.S., Park S.H., Lee G.Y., Lee B.H., Kim C.H., Kang Y.M., Lee W.K., Kam S., Park R.W., Kim I.S., Cho Y.L., Jung T.H., and Park J.Y. DNMT3B polymorphisms and risk of primary lung cancer. Carcinogenesis 26 (2005) 403-409
16. Liu Z., Calderon J.I., Zhang Z., Sturgis E.M., Spitz M.R., and Wei Q. Polymorphisms of vitamin D receptor gene protect against the risk of head and neck cancer. Pharmacogenet. Genomics 15 (2005) 159-165
17. Wang L., Rodriguez M., Kim E.S., Xu Y., Bekele N., El-Naggar A.K., Hong W.K., Mao L., and Oh Y.W. A novel C/T polymorphism in the core promoter of human de novo cytosine DNA methyltransferase 3B6 is associated with prognosis in head and neck cancer. Int. J. Oncol. 25 (2004) 993-999
18. Wang L., Wang J., Sun S., Rodriguez M., Yue P., Jang S.J., and Mao L. A novel DNMT3B subfamily, DeltaDNMT3B, is the predominant form of DNMT3B in non-small cell lung cancer. Int. J. Oncol. 29 (2006) 201-207
19. Clarke L.E., Leitzel K., Smith J., Ali S.M., and Lipton A. Epidermal growth factor receptor mRNA in peripheral blood of patients with pancreatic, lung, and colon carcinomas detected by RT-PCR. Int. J. Oncol. 22 (2003) 425-430
20. Kanai Y., Ushijima S., Kondo Y., Nakanishi Y., and Hirohashi S. DNA methyltransferase expression and DNA methylation of CPG islands and peri-centromeric satellite regions in human colorectal and stomach cancers. Int. J. Cancer 91 (2001) 205-212
21. Mizuno S., Chijiwa T., Okamura T., Akashi K., Fukumaki Y., Niho Y., and Sasaki H. Expression of DNA methyltransferases DNMT1, 3A, and 3B in normal hematopoiesis and in acute and chronic myelogenous leukemia. Blood 97 (2001) 1172-1179
22. Nagai M., Nakamura A., Makino R., and Mitamura K. Expression of DNA (5-cytosin)-methyltransferases (DNMTs) in hepatocellular carcinomas. Hepatol. Res. 26 (2003) 186-191
23. Patra S.K., Patra A., Zhao H., and Dahiya R. DNA methyltransferase and demethylase in human prostate cancer. Mol. Carcinog. 33 (2002) 163-171
24. Robertson K.D., Uzvolgyi E., Liang G., Talmadge C., Sumegi J., Gonzales F.A., and Jones P.A. The human DNA methyltransferases (DNMTs) 1, 3a and 3b: coordinate mRNA expression in normal tissues and overexpression in tumors. Nucleic Acids Res. 27 (1999) 2291-2298
25. Saito Y., Kanai Y., Nakagawa T., Sakamoto M., Saito H., Ishii H., and Hirohashi S. Increased protein expression of DNA methyltransferase (DNMT) 1 is significantly correlated with the malignant potential and poor prognosis of human hepatocellular carcinomas. Int. J. Cancer 105 (2003) 527-532
26. Yakushiji T., Uzawa K., Shibahara T., Noma H., and Tanzawa H. Over-expression of DNA methyltransferases and CDKN2A gene methylation status in squamous cell carcinoma of the oral cavity. Int. J. Oncol. 22 (2003) 1201-1207
27. Aung P.P., Matsumura S., Kuraoka K., Kunimitsu K., Yoshida K., Matsusaki K., Nakayama H., and Yasui W. No evidence of correlation between the single nucleotide polymorphism of DNMT3B promoter and gastric cancer risk in a Japanese population. Oncol. Rep. 14 (2005) 1151-1154
28. Teodoridis J.M., Hall J., Marsh S., Kannall H.D., Smyth C., Curto J., Siddiqui N., Gabra H., McLeod H.L., Strathdee G., and Brown R. CpG island methylation of DNA damage response genes in advanced ovarian cancer. Cancer Res. 65 (2005) 8961-8967
29. Hong Y.S., Lee H.J., You C.H., Roh M.S., Kwak J.Y., Lee M.J., and Kim J.Y. DNMT3B 39179GT polymorphism and the risk of adenocarcinoma of the colon in Koreans. Biochem. Genet. 45 (2007) 155-163
30. Chang K.P., Hao S.P., Liu C.T., Cheng M.H., Chang Y.L., Lee Y.S., Wang T.H., and Tsai C.N. Promoter polymorphisms of DNMT3B and the risk of head and neck squamous cell carcinoma in Taiwan: a case-control study. Oral. Oncol. 43 (2007) 345-351